NEOGENOMICS INC — Director's Dealing 2019

Nov 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-10-31

Reporting Person: SHOVLIN ROBERT J. (President, Clinical Services)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-31	Common Stock	M	96166	$8.03	Acquired	251914	Direct
2019-10-31	Common Stock	S	70473	$23.11	Disposed	181441	Direct
2019-11-01	Common Stock	S	35801	$22.74	Disposed	145640	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-31	Stock Option (Right to Buy)	$8.03	M	96166	Disposed	2023-02-26	Common Stock (96166.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (66667.0)	66667	Direct
Stock Option (Right to Buy)	$19.6	2024-03-01	Common Stock (66897.0)	66897	Direct

Footnotes

F1: On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F2: On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F3: On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. The options vest ratably over the first four anniversary dates of the grant date